Table of Contents    
ARTICLE
Year : 2011  |  Volume : 2  |  Issue : 3  |  Page : 73  

In Silico structure based drug designing for schizophrenia


JUIT, Waknaghat, Solan, H.P., Shimla, India

Date of Web Publication26-May-2012

Correspondence Address:
Manika Sehgal
JUIT, Waknaghat, Solan, H.P., Shimla
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

How to cite this article:
Sehgal M. In Silico structure based drug designing for schizophrenia. J Nat Sc Biol Med 2011;2, Suppl S1:73

How to cite this URL:
Sehgal M. In Silico structure based drug designing for schizophrenia. J Nat Sc Biol Med [serial online] 2011 [cited 2020 Mar 29];2, Suppl S1:73. Available from: http://www.jnsbm.org/text.asp?2011/2/3/73/95844

The current paper aims to design an in silico structure-based drug for treating the disease Schizophrenia. The word Schizophrenia ("split mind") was coined by Eugen Bleuler in 1908.The disease manifests as abnormal thought processes, behaviour and perception. The disease has been found to affect a part of the brain called Substantia nigra. An excessive amount of the neurotransmitter-dopamine bombards the mesolimbic pathway in which transmission of dopamine occurs from Substantia nigra to striatum. From the research work done over many years, it was found that an increased level of dopamine causes Schizophrenia. Excessive binding of this neurotransmitter to Dopamine receptor D2 (DRD2), a G protein-coupled receptor, leads to the hyperactivity of DRD2 causing over-inhibition of adenylyl cyclase which results in the symptoms of schizophrenia. In the current project, attempts have been made to use DRD2 as the potential drug target to cure Schizophrenia. Dopamine Receptor D2 protein in humans is encoded by the DRD2 gene. It has been reported that the DRD2 inhibitors can control the hyperactivity of DRD2, helping to cure the symptoms of Schizophrenia. Various software and computational tools have been used to design the putative drug for the potential treatment of Schizophrenia.




 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed1291    
    Printed69    
    Emailed0    
    PDF Downloaded174    
    Comments [Add]    

Recommend this journal